May well 19th, 2022
8:00 PM – 9:00 PM ET
There ended up over 400 specialty physician teams that entered into strategic partnership transactions during 2021 with healthcare investors, a 90% maximize over every single of the prior a number of yrs.
The “newest” physician specialties that have captivated investor attention are cardiology and vascular practices, with 5 lively platforms now, which is expected to double to ten more than the next 12-18 months. As we have viewed in other specialties, there is a high quality benefit placed on early entrants to sector.
These partnerships can be extremely beneficial to medical professionals, but a transaction is not correct for every single team. It is essential, at a minimal, for doctors to examine the phrases of a potential deal prior to determining if it is ideal for their certain practice.
Sign up for interventional cardiologist Jeffrey Carr, healthcare investment decision banker Robert Goettling, and doctor transactions lawyer Gary Herschman for this instructional dialogue on cardiology and vascular transactions.
This webinar will educate cardiologists and vascular surgeons on different matters relating to this trend, like:
- Why so a lot of cardiology and vascular techniques are checking out and will be entering into strategic investor transactions, like various macro- and microeconomic things
- Why cardiology and vascular practices are really valued in this “super-hot” industry
- The pros and cons of entering into these transactions, and how to best safeguard the interests of medical professionals in both the small and extended expression.
- How to unwind “PSAs” with hospitals, to enable teams to benefit from these much much more rewarding trader partnership transactions.
Registration is complimentary, but pre-registration is expected.
If you have any questions, make sure you reach out to Jack O’Connell.
Members of the media, please speak to Piper Corridor.